Albion Financial Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-68,959
Closed -$7.2M 204
2017
Q4
$7.2M Sell
68,959
-2,052
-3% -$232K 1.1% 28
2017
Q3
$10.4M Sell
71,011
-662
-0.9% -$90.2K 1.58% 19
2017
Q2
$9.31M Sell
71,673
-337
-0.5% -$41.3K 1.55% 18
2017
Q1
$8.96M Buy
72,010
+2,536
+4% +$303K 1.34% 19
2016
Q4
$8.04M Buy
69,474
+293
+0.4% +$32.6K 1.33% 25
2016
Q3
$7.23M Sell
69,181
-85,671
-55% -$9.27M 1.24% 23
2016
Q2
$15.3M Sell
154,852
-415
-0.3% -$42.9K 2.75% 5
2016
Q1
$15.5M Buy
155,267
+11,552
+8% +$1.19M 2.64% 4
2015
Q4
$17.2M Sell
143,715
-889
-0.6% -$103K 2.96% 6
2015
Q3
$15.6M Buy
144,604
+1,093
+0.8% +$136K 2.83% 8
2015
Q2
$16.6M Sell
143,511
-358
-0.2% -$40.9K 2.76% 7
2015
Q1
$16.6M Buy
143,869
+940
+0.7% +$112K 2.82% 8
2014
Q4
$16M Buy
142,929
+390
+0.3% +$41.1K 2.76% 7
2014
Q3
$13.5M Buy
142,539
+1,554
+1% +$140K 2.39% 8
2014
Q2
$12.1M Buy
140,985
+125,193
+793% +$9.52M 2.1% 10
2014
Q1
$1.1M Hold
15,792
0.2% 69
2013
Q4
$1.33M Sell
15,792
-200
-1% -$15.8K 0.25% 55
2013
Q3
$1.23M Hold
15,992
0.26% 56
2013
Q2
$935K Buy
+15,992
New +$962K 0.21% 66

Other funds holding CELG

Albion Financial Group's CELG Position: Q1 2018 in Review

Albion Financial Group sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 68,959 shares — an estimated $7.2M sold.

Albion Financial Group first reported a position in CELG in Q2 2013 and held it in 19 quarters. The position peaked at $17.2M in Q4 2015. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Albion Financial Group reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Albion Financial Group sold 68,959 Celgene Corp shares in Q1 2018, an estimated $7.2M.
  • Albion Financial Group first reported a position in Celgene Corp in Q2 2013 and held it in 19 quarters.
  • Albion Financial Group's Celgene Corp position peaked at $17.2M in Q4 2015.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Albion Financial Group's 13F filing for Q1 2018, filed 17 Apr 2018.